Lakewood is holding COVID-19 vaccine booster clinics October 4th-7th from 5 to 6:30 p.m. at our Main Campus (enter through Entrance B on the south end of the building).
Call 218-894-1515 (option 2) to schedule or register online. Walk-ins are available. Please bring your vaccine card to your appointment.
There will also be a drive thru clinic on Saturday, October 9th from 9 a.m. to 12 p.m. Call 218-894-1515 (option 2) to schedule or register online. This clinic is by appointment only.
Please see below for information regarding who should/may get a booster.
The Food and Drug Administration (FDA) amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine on Sept. 22, 2021, to allow for use of a single booster dose in certain populations. On Sept. 23, 2021, CDC’s Advisory Committee on Immunization Practices (ACIP) met and voted on their recommendations. On Sept. 24, 2021, the CDC director endorsed the ACIP’s recommendations and made an additional recommendation for those in high-risk occupational and institutional settings.
The following groups should get a booster dose of Pfizer COVID-19 vaccine at least six months after the second dose:
- People 65 years and older
- Residents in long-term care settings
- People ages 50 to 64 with certain underlying medical conditions (refer to CDC: People with Certain Medical Conditions)
The following groups may get a booster dose of Pfizer’s COVID-19 vaccine at least six months after the second dose, if the personal benefits for them outweigh the personal risks:
- People ages 18 to 49 who are at high risk for severe COVID-19 due to certain underlying medical conditions (refer to CDC: People with Certain Medical Conditions)
- People ages 18 to 64 who are at increased risk for COVID-19 exposure and transmission because of where they live or work
*These recommendations are only for those who received Pfizer-BioNTech vaccine as their primary series. No authorizations or recommendations on a booster dose were made for those who received Moderna or Johnson & Johnson (Janssen) vaccine for their primary series at this time.